ArticleOncotarget2015

Loss of p21Cip1/CDKN1A renders cancer cells susceptible to Polo-like kinase 1 inhibition.

Nina-Naomi Kreis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.